BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. glucose metabolic process, Lung cancer, Adipose tissue, Laryngoscope, Rapamycin, DRD2)
Bookmark Forward

13-valent pneumococcal vaccine: 50 years of age and older.

Prescrire international 2013 Feb


filter terms:
  • 13 valent pneumococcal vaccine (2)
  • 23- valent vaccine (1)
  • adults (2)
  • age (1)
  • age factors (1)
  • conjugate vaccine (1)
  • humans (1)
  • middle aged (1)
  • patient selection (1)
  • pneumococcal infections (1)
  • pneumococcal vaccine (3)
  • risk assessment (1)
  • risk factors (1)
  • vaccination (2)
    • Sizes of these terms reflect their relevance to your search.

    In adults, the 13-valent pneumococcal conjugate vaccine seems to be more immunogenic than the 23-valent polysaccharide pneumococcal vaccine for most of the 12 shared serotypes. However, in mid-2012, routine vaccination of adults has no proven efficacy.

    Citation

    13-valent pneumococcal vaccine: 50 years of age and older. Prescrire international. 2013 Feb;22(135):38

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 23444498

    View Full Text
    • Copyright © 2021 Illumina Inc. All rights reserved.